Inhibition of Ras and Related Guanosine Triphosphate-dependent Proteins as a Therapeutic Strategy for Blocking Malignant Glioma Growth: II-Preclinical Studies in a Nude Mouse Model

This publication has 30 references indexed in Scilit:

• Platelet-Derived Growth Factor-Dependent Activation of Phosphatidylinositol 3-Kinase Is Regulated by Receptor Binding of SH2-Domain-Containing Proteins Which Influence Ras Activity
  Molecular and Cellular Biology, 1996
• Disruption of Oncogenic K-Ras4B Processing and Signaling by a Potent Geranylgeranyltransferase I Inhibitor
  Published by Elsevier ,1995
• Ras CAAX Peptidomimetic FTI-277 Selectively Blocks Oncogenic Ras Signaling by Inducing Cytoplasmic Accumulation of Inactive Ras-Raf Complexes
  Published by Elsevier ,1995
• Inhibition of farnesyltransferase induces regression of mammary and salivary carcinomas in ras transgenic mice
  Nature Medicine, 1995
• Protein farnesyltransferase inhibitors block the growth of ras-dependent tumors in nude mice.
  Proceedings of the National Academy of Sciences, 1994
• Farnesyltransferase inhibitors: Ras research yields a potential cancer therapeutic
  Cell, 1994
• Clinical Implications of the p53 Tumor-Suppressor Gene
  New England Journal of Medicine, 1993
• Selective Inhibition of ras -Dependent Transformation by a Farnesyltransferase Inhibitor
  Science, 1993
• Growth Factors and Cancer
  Science, 1991
• p21ras is modified by a farnesyl isoprenoid.
  Proceedings of the National Academy of Sciences, 1989